Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.53511 | 79 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.70095 | 80 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.63773 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.22972 | 83 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.15235 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.38934 | 79 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.1452 | 85 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.53374 | 79 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.23515 | 84 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.62041 | 86 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.35214 | 85 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.43171 | 85 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.48297 | 86 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.27472 | 85 |